Successful treatment of metastatic androgen-independent prostate carcinoma in a transsexual patient

被引：47
作者：
Dorff, Tanya B.
Shazer, Ronald L.
Nepomuceno, Edward M.
Tucker, Steven J.
机构：
[1] Angeles Clin & Res Inst, Los Angeles, CA 90025 USA
[2] Univ Calif Los Angeles, David Gaffen Sch Med, Cedars Sinai Med Ctr, Div Hematol Oncol,Dept Med, Los Angeles, CA 90024 USA
来源：
CLINICAL GENITOURINARY CANCER | 2007年 / 5卷 / 05期
关键词：
adrenolytic therapy; chemotherapy; radiation therapy; second-line therapy;
D O I：
10.3816/CGC.2007.n.016
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The occurrence of prostate carcinoma in transsexual patients has rarely been reported. These cases present a unique challenge in that such patients are effectively receiving androgen deprivation therapy. By definition, their disease is androgen-independent prostate cancer, and the role of local therapy is undefined. We report on a male-to-female transsexual patient with metastatic prostate cancer treated successfully with combination chemotherapy after previous standard therapy failed.
引用
收藏
页码：344 / 346
页数：3
相关论文
共 16 条
  • [1] Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancer
    Beer, TM
    Eilers, KM
    Garzotto, M
    Egorin, MJ
    Lowe, BA
    Henner, WD
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (01) : 123 - 128
  • [2] Bostwick David G, 2004, Clin Prostate Cancer, V2, P228, DOI 10.3816/CGC.2004.n.004
  • [3] BOSTWICK DG, 1994, AM J CLIN PATHOL S, V102, P38
  • [4] Randomized phase II trial of docetaxel plus thalidomide in androgen-independent prostate cancer
    Dahut, WL
    Gulley, JL
    Arlen, PM
    Liu, Y
    Fedenko, KM
    Steinberg, SM
    Wright, JJ
    Parnes, H
    Chen, CC
    Jones, E
    Parker, CE
    Linehan, WM
    Figg, WD
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (13) : 2532 - 2539
  • [5] Paclitaxel, estramustine phosphate, and carboplatin in patients with advanced prostate cancer
    Kelly, WK
    Curley, T
    Slovin, S
    Heller, G
    McCaffrey, J
    Bajorin, D
    Ciolino, A
    Regan, K
    Schwartz, M
    Kantoff, P
    George, D
    Oh, W
    Smith, M
    Kaufman, D
    Small, EJ
    Schwartz, L
    Larson, S
    Tong, W
    Scher, H
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (01) : 44 - 53
  • [6] RADIOTHERAPY FOR REGIONALLY LOCALIZED HORMONE-REFRACTORY PROSTATE-CANCER
    LANKFORD, SP
    POLLACK, A
    ZAGARS, GK
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 33 (04): : 907 - 912
  • [7] A phase II study of estramustine, docetaxel, and carboplatin with granulocyte-colony-stimulating factor support in patients with hormone-refractory prostate carcinoma - Cancer and leukemia group B 99813
    Oh, WK
    Halabi, S
    Kelly, WK
    Werner, C
    Godley, PA
    Vogelzang, NJ
    Small, EJ
    [J]. CANCER, 2003, 98 (12) : 2592 - 2598
  • [8] ESTRAMUSTINE PHOSPHATE SODIUM - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY IN PROSTATE-CANCER
    PERRY, CM
    MCTAVISH, D
    [J]. DRUGS & AGING, 1995, 7 (01) : 49 - 74
  • [9] Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer
    Petrylak, DP
    Tangen, CM
    Hussain, MHA
    Lara, PN,J
    Jones, JA
    Taplin, ME
    Burch, PA
    Berry, D
    Moinpour, C
    Kohli, M
    Benson, MC
    Small, EJ
    Raghavan, D
    Crawford, ED
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (15) : 1513 - 1520
  • [10] COMPARISON OF MAGNETIC-RESONANCE-IMAGING AND ULTRASONOGRAPHY IN STAGING EARLY PROSTATE-CANCER - RESULTS OF A MULTIINSTITUTIONAL COOPERATIVE TRIAL
    RIFKIN, MD
    ZERHOUNI, EA
    GATSONIS, CA
    QUINT, LE
    PAUSHTER, DM
    EPSTEIN, JI
    HAMPER, U
    WALSH, PC
    MCNEIL, BJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (10) : 621 - 626
12